METTL3 enhances PD-L1 expression in BC cells post-transcriptionally through an m6A-IGF2BP3-dependent mechanism, promoting mRNA stability and affecting the efficacy of tumor immunotherapy (105). Here, CD274 is linked to neoplasm.